Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seth M Pollack

Showing results (81-90 of 109) with videos related to

Pageof 11
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 23, 2019
First-in-Class, First-in-Human Study Evaluating LV305, a Dendritic-Cell Tropic Lentiviral Vector, in Sarcoma and Other Solid Tumors Expressing NY-ESO-1Neeta Somaiah, Matthew S Block, Joseph W Kim, et al.
JAMA Oncology|September 10, 2020
Assessment of Doxorubicin and Pembrolizumab in Patients With Advanced Anthracycline-Naive Sarcoma: A Phase 1/2 Nonrandomized Clinical TrialSeth M Pollack, Mary W Redman, Kelsey K Baker, et al.
The Lancet. Oncology|January 19, 2026
Cabozantinib and temozolomide in patients with unresectable or metastatic leiomyosarcoma and other soft tissue sarcomas: a multicentre, single-arm, lead-in phase 2 trialVarun Monga, Scott Okuno, Brian Van Tine, et al.
The Journal of Clinical Investigation|April 29, 2025
DNA demethylating agents suppress preclinical models of synovial sarcomaNobuhiko Hasegawa, Nezha S Benabdallah, Kyllie Smith-Fry, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2019
Mobilization of CD8<sup>+</sup> T Cells via CXCR4 Blockade Facilitates PD-1 Checkpoint Therapy in Human Pancreatic CancerYongwoo David Seo, Xiuyun Jiang, Kevin M Sullivan, et al.
Cancers|March 10, 2022
Immunologic Gene Signature Analysis Correlates Myeloid Cells and M2 Macrophages with Time to Trabectedin Failure in Sarcoma PatientsBrett A Schroeder, Yuzheng Zhang, Kimberly S Smythe, et al.
Cancers|February 10, 2024
Immune Assessment Today: Optimizing and Standardizing Efforts to Monitor Immune Responses in Cancer and BeyondSurya Pandey, Meghan E Cholak, Rishita Yadali, et al.
Cancers|March 6, 2021
Unmet Medical Needs and Future Perspectives for Leiomyosarcoma Patients-A Position Paper from the National LeioMyoSarcoma Foundation (NLMSF) and Sarcoma Patients EuroNet (SPAEN)Bernd Kasper, Annie Achee, Kathrin Schuster, et al.
Cancers|March 13, 2025
Paradoxical Response to Neoadjuvant Therapy in Undifferentiated Pleomorphic Sarcoma: Increased Tumor Size on MRI Associated with Favorable PathologyMariam H Goreish, Nicolò Gennaro, Laetitia Perronne, et al.
Skeletal Radiology|March 3, 2026
Performance of deep learning-based segmentation of soft tissue sarcoma by MRI sequence, tumor type and locationLinkai Peng, Laetitia Perronne, Nicolò Gennaro, et al.
Pageof 11

Showing results (81-90 of 109) with videos related to

Sort By:
Pageof 11
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 23, 2019
First-in-Class, First-in-Human Study Evaluating LV305, a Dendritic-Cell Tropic Lentiviral Vector, in Sarcoma and Other Solid Tumors Expressing NY-ESO-1Neeta Somaiah, Matthew S Block, Joseph W Kim, et al.
JAMA Oncology|September 10, 2020
Assessment of Doxorubicin and Pembrolizumab in Patients With Advanced Anthracycline-Naive Sarcoma: A Phase 1/2 Nonrandomized Clinical TrialSeth M Pollack, Mary W Redman, Kelsey K Baker, et al.
The Lancet. Oncology|January 19, 2026
Cabozantinib and temozolomide in patients with unresectable or metastatic leiomyosarcoma and other soft tissue sarcomas: a multicentre, single-arm, lead-in phase 2 trialVarun Monga, Scott Okuno, Brian Van Tine, et al.
The Journal of Clinical Investigation|April 29, 2025
DNA demethylating agents suppress preclinical models of synovial sarcomaNobuhiko Hasegawa, Nezha S Benabdallah, Kyllie Smith-Fry, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2019
Mobilization of CD8<sup>+</sup> T Cells via CXCR4 Blockade Facilitates PD-1 Checkpoint Therapy in Human Pancreatic CancerYongwoo David Seo, Xiuyun Jiang, Kevin M Sullivan, et al.
Cancers|March 10, 2022
Immunologic Gene Signature Analysis Correlates Myeloid Cells and M2 Macrophages with Time to Trabectedin Failure in Sarcoma PatientsBrett A Schroeder, Yuzheng Zhang, Kimberly S Smythe, et al.
Cancers|February 10, 2024
Immune Assessment Today: Optimizing and Standardizing Efforts to Monitor Immune Responses in Cancer and BeyondSurya Pandey, Meghan E Cholak, Rishita Yadali, et al.
Cancers|March 6, 2021
Unmet Medical Needs and Future Perspectives for Leiomyosarcoma Patients-A Position Paper from the National LeioMyoSarcoma Foundation (NLMSF) and Sarcoma Patients EuroNet (SPAEN)Bernd Kasper, Annie Achee, Kathrin Schuster, et al.
Cancers|March 13, 2025
Paradoxical Response to Neoadjuvant Therapy in Undifferentiated Pleomorphic Sarcoma: Increased Tumor Size on MRI Associated with Favorable PathologyMariam H Goreish, Nicolò Gennaro, Laetitia Perronne, et al.
Skeletal Radiology|March 3, 2026
Performance of deep learning-based segmentation of soft tissue sarcoma by MRI sequence, tumor type and locationLinkai Peng, Laetitia Perronne, Nicolò Gennaro, et al.
Pageof 11